XML 43 R31.htm IDEA: XBRL DOCUMENT v3.23.3
Share-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Shares Available for Grant
The following table summarizes the shares available for grant under the 2018 Plan:
Shares Available for Grant
Balance - December 31, 20227,848,832 
Authorized2,144,521 
Granted(2,172,448)
Shares withheld to cover taxes26,016 
Forfeited665,294 
Balance - September 30, 20238,512,215 
Schedule of Fair Value Assumptions Following are the assumptions used in the Black-Scholes valuation model for options granted during the periods shown below:
Three Months EndedNine Months Ended
September 30,
2023
October 1,
2022
September 30,
2023
October 1,
2022
Risk-free interest rateN/AN/A4.1%1.9%
Average expected term (years)N/AN/A7.07.0
Expected volatilityN/AN/A55.3%55.0%
Dividend yieldN/AN/A
Schedule of Stock Option Activity
The following table summarizes the Company’s stock option activity during the nine months ended September 30, 2023:
Number
of
Stock
Options
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life (Years)
Aggregate
Intrinsic
Value (in thousands)(1)
Outstanding at December 31, 20223,999,933 $25.58 5.3$20,712 
Granted1,014,718 $17.84 $— 
Exercised(215,943)$0.79 $3,646 
Canceled/Forfeited(415,082)$36.76 $— 
Outstanding at September 30, 20234,383,626 $23.95 5.6$13,670 
Vested and exercisable at September 30, 20233,056,564 $22.82 4.0$13,670 
Vested and expected to vest at September 30, 20234,214,949 $23.69 5.4$13,670 
__________
(1) Aggregate intrinsic value is calculated as the difference between the value of common stock on the transaction date and the exercise price multiplied by the number of shares issuable under the stock option. Aggregate intrinsic value of shares outstanding at the beginning and end of the reporting period is calculated as the difference between the value of common stock on the beginning and end dates, respectively, and the exercise price multiplied by the number of shares outstanding.
Schedule of RSU Activity
The following table summarizes the Company’s RSU activity during the nine months ended September 30, 2023:
Number of UnitsWeighted
Average
Grant Date Fair Value Per Unit
Unvested at December 31, 2022993,313 $35.98 
Granted1,157,730 $16.52 
Vested(1)
(500,922)$30.74 
Canceled/Forfeited(250,212)$28.99 
Unvested at September 30, 20231,399,909 $23.01 
________
(1) Includes 26,016 shares of common stock that were withheld to cover taxes on the release of vested RSUs and became available for future grants pursuant to the 2018 Plan.